Admission hyperglycemia is a poor prognostic sign in both diabetics and non-diabetics

Abstract EN

To study the prognostic effect of admission hyperglycemia in known and unknown diabetics who were admitted to the general medical ward.

A random sample of patients admitted to the medical ward over one year who had blood glucose measurement on admission was selected.

In addition to demographic data, the following data were recorded; blood glucose measurement on admission, duration of hospital stay, admission to intensive care unit, presence of coronary heart disease, renal failure, and infection.

A total of 480 patients were studied.

Admission hyperglycemia were present in 170 (36 %), 139 (29 %) were known diabetics, and 31 (7 %) were new hyperglycemia.

New hyperglycemic had a longer hospital stay compared to both diabetics and non-diabetics; 20 days versus 15 days in diabetics, p 0.01 and 11 days in non-diabetics p 0.001.

In addition new hyperglycemia had a higher in hospital mortality compared to diabetics and non-diabetics ; 19% versus 12 % in diabetics p 0.04 and versus 9% in non-diabetics p.

001.

Higher intensive care admission were also reported in new hyperglycemic compared to diabetics and nondiabetics; 36% versus 22 % in diabetics p 0.

01 and versus 13% in nondiabetics p 0.001.

Admission hyperglycemia is a common finding.

New hyperglycemia is significantly associated with higher in-hospital mortality, intensive care unit admission, and longer hospital stay.